NCT00609011 2010-08-23Phase 1 Study of MPC-6827 and Temozolomide in Metastatic MelanomaMyrexis Inc.Phase 1/2 Completed22 enrolled
NCT00393965 2008-02-13Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain MetastasesMyrexis Inc.Phase 1 Completed18 enrolled